Schonfeld Strategic Advisors »

An2 Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $18k 14k 1.27
2025-06-30 $18k 17k 1.06
2025-03-31 $27k 20k 1.36
2024-12-31 $37k 27k 1.38
2024-09-30 $71k 66k 1.07
2024-06-30 $47k 22k 2.15

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Ethereum Tr SHS (ETHA)
Fidelity Wise Origin Bitcoin SHS (FBTC)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ark 21shares Bitcoin Etf Shs Ben Int (ARKB)
Broadcom (AVGO)
Ishares Tr Core S&p500 Etf (IVV)
Alibaba Group Hldg Sponsored Ads (BABA)
Union Pacific Corporation (UNP)
Tesla Motors (TSLA)
Marvell Technology (MRVL)
Boston Scientific Corporation (BSX)

View all positions for Schonfeld Strategic Advisors

Top funds holding An2 Therapeutics

Almitas Capital
Vanguard Group
Pfizer
Peapod Lane Capital
Stonepine Capital Management
Bank of Nova Scotia
Landscape Capital Management
Bank Of Montreal
Renaissance Technologies
BlackRock
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Morgan Stanley
State Street Corporation

View all funds holding An2 Therapeutics